What is Dolutegravir?
Category: Prescription Drugs
Most popular types: Tivicay Tivicay HIV Post-Exposure Prophylaxis
See also: Abacavir-dolutegravir-lamivudine Triumeq
Dolutegravir is a drug used in combination with other anti-retroviral drugs to treat HIV (Human Immunodeficiency Virus). It is an integrase inhibitor, meaning that it interferes with the replication of the virus in the human body.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Human immunodeficiency virus (HIV) | 16 | 7 | |
| HIV exposure | 1 | 1 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Why patients stopped taking Dolutegravir
Multiple reasons could be selected
| Reason | Patients | |
|---|---|---|
| Other | 2 | |
| Course of treatment ended | 1 |
Duration
Currently taking Dolutegravir
| Duration | Patients | |
|---|---|---|
| 1 - 6 months | 1 | |
| 1 - 2 years | 3 | |
| 2 - 5 years | 7 |
Stopped taking Dolutegravir
| Duration | Patients | |
|---|---|---|
| Less than 1 month | 1 | |
| 6 months - 1 year | 1 | |
| 1 - 2 years | 1 |
What people switch to and from
Patients started taking Dolutegravir after stopping:
| Treatment | Patients | |
|---|---|---|
| Darunavir (Prezista) | 3 | |
| Ritonavir (Norvir) | 3 | |
| Raltegravir (Isentress) | 2 | |
| Cobicistat-elvitegravir-emtricitabine-tenofovir disoproxil (Stribild) | 1 | |
| Efavirenz (Sustiva) | 1 |
Patients stopped taking Dolutegravir and switched to:
| Treatment | Patients | |
|---|---|---|
| Triumeq | 3 |
Last updated: